Monday, September 14, 2026

Celtrion’s Steqeyma Seizes 16% Market Share in the U.S.: What’s Next for This Autoimmune Treatment?

Celltrion's autoimmune drug Steqeyma surpasses 16% market share in the U.S., accelerating prescription growth and expansion.

U.S. and South Korea Gear Up for Major Military Drills Amid North Korean Tensions

Ulchi Freedom Shield (UFS) exercise will be notable for incorporating a scenario involving a North Korean nuclear attack for the first time.

Tag: indictment

No posts to display

Top News

- Our Sponsors Ad -

Follow us